Australian (ASX) Pharmaceuticals & Biotech Dividend Stocks
UPDATED May 20, 2026
Discover Australian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the ASX and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
VIT | AU$0.036 | -5.3% | -47.1% | AU$23.9m | n/a | 30.4 | n/a | 5.6% | ||
VLS | AU$2.56 | 5.8% | 42.2% | AU$139.1m | n/a | 13.3 | n/a | 5.5% | ||
CSL | AU$100.05 | 2.9% | -59.4% | AU$47.8b | AU$148.45 | 24.8 | 40.1% | 4.1% | ||
CUV | AU$9.22 | -3.4% | -12.7% | AU$450.8m | AU$23.20 | 14.3 | 24.9% | 0.5% | ||
CTE | AU$1.07 | 7.0% | 40.8% | AU$48.8m | n/a | 23.9 | n/a | 0% | ||
ACR | AU$0.009 | -18.2% | -60.9% | AU$5.1m | n/a | 1.6 | n/a | 0% | ||
MVP | AU$0.40 | -7.0% | -34.4% | AU$45.1m | AU$2.03 | 1.1 | 80.0% | 0% |
Page 1 of 1